Date & time
Thursday, May 12, 2016
4 p.m. – 5 p.m.
4 p.m. – 5 p.m.
Conferences & lectures
Share this event:
Alumni Roundtable: Biotech venture capitalist
Cost
This event is free
Where
J.W. McConnell Building
1400 De Maisonneuve W.
Room LB-362
Wheel chair accessible
Yes
Thursday, May 12, 2016
- 4 p.m.-5 p.m.
- J.W. McConnell Building, LB-362, 1400 De Maisonneuve Blvd. W.
Meet Inès Holzbaur, BSc (chemistry) 94, vice-president, GeneChem.
Who better to guide the next generation than their alumni predecessors? In these small-group roundtable conversations, we invite accomplished alumni to meet with members of the graduating class and share expertise, inspiration and practical knowhow on taking the next steps into the workplace. It's part mentoring, part interview session, all knowledge!
- Complimentary admission
- Registration required
- Business casual attire recommended
Part of the 2016 Alumni Matters graduation transition conference, this event is reserved for fall 2015 and spring 2016 graduates.
About the speaker:
Inès Holzbaur, BSc 94, is a general partner at AmorChem, a life sciences venture capital fund. In 2011, she participated in the origination and establishment of AmorChem’s disruptive model for financing very early-stage drug development projects. As part of the fund’s activities, she played an important role in closing a transaction which led to the pharmaceutical company Roche entering into a strategic alliance with AmorChem to develop a drug to treat myotonic dystrophy type 1. She began her career in 1999 as a manager and then vice-president of the GeneChem and AgeChem venture capital funds. During this period, she financed of several companies in Canada, the U.S. and Europe. As a result, she has held positions on the board of a number of companies, including BioVex inc., which was sold to Amgen for $1B and Argos Therapeutics inc., which recently obtained a NASDAQ listing. In addition to her BSc in chemistry from Concordia, she holds a PhD in chemistry from Cambridge University in the U.K.